These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34988427)

  • 1. High frequency of psychosis in late-stage Parkinsońs disease.
    Chendo I; Fabbri M; Godinho C; Moiron Simões R; Severiano Sousa C; Coelho M; Voon V; Ferreira JJ
    Clin Park Relat Disord; 2021; 5():100119. PubMed ID: 34988427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High frequency of Depressive Disorders and Suicidal Phenomena in Late-Stage Parkinson´s Disease - A Cross-Sectional Study.
    Chendo I; Fabbri M; Godinho C; Simões RM; Sousa CS; Coelho M; Voon V; Ferreira JJ
    J Geriatr Psychiatry Neurol; 2023 Jul; 36(4):336-346. PubMed ID: 36278309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive identification of delusions and olfactory, tactile, gustatory, and minor hallucinations in Parkinson's disease psychosis.
    Kulick CV; Montgomery KM; Nirenberg MJ
    Parkinsonism Relat Disord; 2018 Sep; 54():40-45. PubMed ID: 29653909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of psychotic symptoms in a community-based Parkinson disease sample.
    Mack J; Rabins P; Anderson K; Goldstein S; Grill S; Hirsch ES; Lehmann S; Little JT; Margolis RL; Palanci J; Pontone G; Weiss H; Williams JR; Marsh L
    Am J Geriatr Psychiatry; 2012 Feb; 20(2):123-32. PubMed ID: 21617521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of non-motor symptoms to levodopa in late-stage Parkinson's disease: Results of a levodopa challenge test.
    Fabbri M; Coelho M; Guedes LC; Chendo I; Sousa C; Rosa MM; Abreu D; Costa N; Godinho C; Antonini A; Ferreira JJ
    Parkinsonism Relat Disord; 2017 Jun; 39():37-43. PubMed ID: 28389156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Psychoses in patients with Parkinson's disease; their frequency, phenomenology, and clinical correlates].
    Kashihara K; Ohno M; Katsu Y
    Rinsho Shinkeigaku; 2005 Jan; 45(1):1-5. PubMed ID: 15714992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does an association between cigarette smoking and Parkinson's Disease-related psychosis exist? Insights from a large non-demented cohort.
    Terravecchia C; Mostile G; Rascunà C; Arabia G; Barone P; Marconi R; Morgante L; Quattrone A; Nicoletti A; Zappia M
    J Neurol Sci; 2021 Aug; 427():117509. PubMed ID: 34082149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics, correlates, and assessment of psychosis in Parkinson disease without dementia.
    Barrett MJ; Smolkin ME; Flanigan JL; Shah BB; Harrison MB; Sperling SA
    Parkinsonism Relat Disord; 2017 Oct; 43():56-60. PubMed ID: 28735797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychosis in Parkinson's disease without dementia: common and comorbid with other non-motor symptoms.
    Lee AH; Weintraub D
    Mov Disord; 2012 Jun; 27(7):858-63. PubMed ID: 22674352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do patients with late-stage Parkinson's disease still respond to levodopa?
    Fabbri M; Coelho M; Abreu D; Guedes LC; Rosa MM; Costa N; Antonini A; Ferreira JJ
    Parkinsonism Relat Disord; 2016 May; 26():10-6. PubMed ID: 26972527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysphagia predicts poor outcome in late-stage Parkinson's disease.
    Fabbri M; Coelho M; Abreu D; Guedes LC; Rosa MM; Godinho C; Cardoso R; Guimaraes I; Antonini A; Zibetti M; Lopiano L; Ferreira JJ
    Parkinsonism Relat Disord; 2019 Jul; 64():73-81. PubMed ID: 30902528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency and Characteristics of Psychosis in Parkinson's Disease: A Systematic Review and Meta-Analysis.
    Chendo I; Silva C; Duarte GS; Prada L; Voon V; Ferreira JJ
    J Parkinsons Dis; 2022; 12(1):85-94. PubMed ID: 34806620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening, Diagnosis, and Management of Parkinson's Disease Psychosis: Recommendations From an Expert Panel.
    Pahwa R; Isaacson SH; Small GW; Torres-Yaghi Y; Pagan F; Sabbagh M
    Neurol Ther; 2022 Dec; 11(4):1571-1582. PubMed ID: 35906500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pimavanserin, a serotonin(2A) receptor inverse agonist, for the treatment of parkinson's disease psychosis.
    Meltzer HY; Mills R; Revell S; Williams H; Johnson A; Bahr D; Friedman JH
    Neuropsychopharmacology; 2010 Mar; 35(4):881-92. PubMed ID: 19907417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and Genetic Analysis of Psychosis in Parkinson's Disease.
    Radojević B; Dragašević-Mišković NT; Marjanović A; Branković M; Dobričić V; Milovanović A; Tomić A; Svetel M; Petrović I; Jančić I; Stanisavljević D; Savić MM; Kostić VS
    J Parkinsons Dis; 2021; 11(4):1973-1980. PubMed ID: 34151861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychiatric co-morbidities in non-demented Parkinson's disease.
    Rai NK; Goyal V; Kumar N; Shukla G; Srivastava AK; Singh S; Behari M
    Ann Indian Acad Neurol; 2015; 18(1):33-8. PubMed ID: 25745308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges in managing late-stage Parkinson's disease: Practical approaches and pitfalls.
    Williams L; Qiu J; Waller S; Tsui D; Griffith J; Fung VSC
    Aust J Gen Pract; 2022 Oct; 51(10):778-785. PubMed ID: 36184862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the National Institute of Neurological Disorders and Stroke Criteria for Psychosis in Parkinson Disease.
    Gordon PC; Rocha MS; Kauark RG; Costa CD; de Oliveira MO; Godinho F; Borges V
    Am J Geriatr Psychiatry; 2017 Jan; 25(1):73-80. PubMed ID: 27742525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvements in both psychosis and motor signs in Parkinson's disease, and changes in regional cerebral blood flow after electroconvulsive therapy.
    Usui C; Hatta K; Doi N; Kubo S; Kamigaichi R; Nakanishi A; Nakamura H; Hattori N; Arai H
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1704-8. PubMed ID: 21605615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychiatric symptoms screening in the early stages of Parkinson's disease.
    Bugalho P; da Silva JA; Cargaleiro I; Serra M; Neto B
    J Neurol; 2012 Jan; 259(1):124-31. PubMed ID: 21691730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.